Requip XL (Ropinirole ER)

Information about Requip XL (Ropinirole ER)

Requip XL (Ropinirole ER) is the extended-release formulation of Ropinirole, a medication used primarily to treat Parkinson's disease and Restless Legs Syndrome (RLS). The extended-release version provides a longer-lasting effect, which allows for once-daily dosing, offering improved convenience and potentially better management of symptoms throughout the day and night.

Product Highlights

• To manage the motor symptoms such as tremors, rigidity, and bradykinesia associated with Parkinson's disease.
• To relieve the uncomfortable urge to move the legs, particularly during periods of rest or sleep.

Key Ingredient

• Ropinirole

Key Benefits

• The extended-release formulation provides continuous symptom relief over 24 hours, making it more convenient for patients.
• Aids in controlling motor symptoms of Parkinson's disease, including stiffness and tremors. 
• Reduces the uncomfortable sensations and urges to move the legs in patients with Restless Legs Syndrome, particularly during the night.
• The extended-release format allows for easier adherence to the treatment regimen, as it requires only one dose per day.
• Helps maintain a steady level of medication throughout the day, potentially improving the quality of life for patients.

Direction of Use

• Requip XL (Ropinirole ER) should be taken once a day, with or without food. 
• It should be swallowed whole and not crushed, split, or chewed.
• The dosage may start low and gradually increase based on the patient's individual needs and tolerance.
• The extended-release tablets are designed to release medication over a 24-hour period, so it's important to follow the prescribed dosing schedule.
• For Parkinson's disease, the dosage may be adjusted according to the patient's clinical response. 
• For Restless Legs Syndrome, Requip XL should be taken 1-3 hours before bedtime.

Safety Concerns

• Requip XL can cause drowsiness, and in some cases, patients may experience sudden sleep attacks without warning.
• Some individuals may experience a drop in blood pressure when standing, leading to dizziness or fainting.
• Especially in elderly patients, Requip XL can cause psychiatric side effects, such as hallucinations or confusion.
• There is a risk of developing compulsive behaviors, such as gambling, hypersexuality, or binge eating.
• Common side effects, especially when increasing the dose.
• May occur, especially when standing up quickly.

Avoid Requip XL (Ropinirole ER) If

• You are allergic to ropinirole or any of the ingredients in Requip XL. 
• You have severe liver problems as Requip XL is metabolized by the liver and may cause complications.
• You have a history of severe psychiatric disorders (e.g., psychosis or hallucinations).
• You have orthostatic hypotension (severe low blood pressure upon standing).
• You are pregnant or breastfeeding, unless advised otherwise by your doctor, as safety during pregnancy and lactation is not fully established.
• You have a history of impulse control disorders (such as gambling or hypersexuality).
• You are taking certain medications that may interact with Requip XL, such as some antidepressants, antipsychotics, or other dopamine agonists.